Sg Americas Securities, LLC Adverum Biotechnologies, Inc. Transaction History

Sg Americas Securities, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$0.81 - $1.34 $10,184 - $16,847	-12,573 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$1.23 - $1.95 $14,656 - $23,236	-11,916 Reduced 48.66%	12,573 $16,000
Q4 2021 Feb 07, 2022	SELL	$1.74 - $2.4 $77,334 - $106,668	-44,445 Reduced 64.47%	24,489 $43,000
Q3 2021 Nov 01, 2021	BUY	$2.08 - $3.6 $143,382 - $248,162	68,934 New	68,934 $150,000
Q2 2021 Aug 12, 2021	SELL	$3.36 - $10.56 $69,185 - $217,440	-20,591 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$9.26 - $14.36 $50,828 - $78,822	5,489 Added 36.35%	20,591 $203,000
Q4 2020 Feb 04, 2021	SELL	$9.84 - $14.26 $818,215 - $1.19 Million	-83,152 Reduced 84.63%	15,102 $164,000
Q3 2020 Nov 09, 2020	BUY	$10.3 - $21.64 $892,052 - $1.87 Million	86,607 Added 743.6%	98,254 $1.01 Million
Q2 2020 Jul 20, 2020	SELL	$8.53 - $25.64 $321,913 - $967,627	-37,739 Reduced 76.42%	11,647 $243,000
Q1 2020 Apr 30, 2020	BUY	$7.98 - $16.32 $394,100 - $805,979	49,386 New	49,386 $483,000
Q4 2019 Jan 28, 2020	SELL	$5.12 - $12.22 $192,225 - $458,787	-37,544 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$5.24 - $15.89 $196,730 - $596,574	37,544 New	37,544 $205,000
Q2 2019 Jul 29, 2019	SELL	$5.1 - $11.89 $57,956 - $135,117	-11,364 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$3.03 - $6.02 $34,432 - $68,411	11,364 New	11,364 $60,000
Q3 2018 Nov 06, 2018	SELL	$4.5 - $7.6 $48,487 - $81,890	-10,775 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$5.3 - $6.9 $57,107 - $74,347	10,775 New	10,775 $57,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $424M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.